Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial dysfunction in hypertension.

W Kiowski1

  • 1Division of Cardiology, Department of Medicine, University Hospital, Zürich, Switzerland.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|July 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans.

Clinical pharmacology and therapeutics·2010
Same author

Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.

Journal of hypertension·2003
Same author

Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.

American heart journal·2003
Same author

[Medicamentous management of acute coronary syndrome without ST segment elevation].

Therapeutische Umschau. Revue therapeutique·2002
Same author

Rationale and perspective of endothelin-1 antagonism in acute heart failure.

Journal of cardiovascular pharmacology·2002
Same author

Clinical picture: Amiodarone-induced pulmonary mass and cutaneous vasculitis.

Lancet (London, England)·2002
Same journal

Adiponectin improves the aortic dissection by inhibiting inflammatory cell infiltration and macrophage pyroptosis.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Electroacupuncture for essential hypertension: Mechanistic insights, current clinical evidence, and translational challenges.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Association of intracranial atherosclerotic stenosis with 1-year cognitive impairment after acute ischemic stroke or transient ischemic attack: a nationwide prospective cohort study.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Frailty as a mediator of the association between hyperuricemia and stroke risk: A prospective cohort study.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Synergistic impact of nondipper heart rate and blood pressure on left ventricular hypertrophy in essential hypertension.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

From clinic to home monitoring: Diagnostic strategies and evidence landscape of white-coat uncontrolled hypertension.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
See all related articles

Hypertension contributes to atherosclerosis via endothelial dysfunction, affecting nitric oxide pathways. Current treatments often fail to reverse this dysfunction, and its precise role in atherosclerosis requires further study.

Area of Science:

  • Cardiovascular Medicine
  • Endothelial Biology
  • Hypertension Research

Background:

  • Hypertension is a major risk factor for atherosclerosis.
  • Endothelial dysfunction, particularly impaired nitric oxide (NO)-mediated vasodilation, is implicated.
  • This dysfunction affects various vascular beds in hypertensive patients.

Purpose of the Study:

  • To investigate the role of endothelial dysfunction in hypertension-related atherosclerosis.
  • To assess the impact of hypertension on nitric oxide-mediated vascular tone.
  • To evaluate the effectiveness of antihypertensive therapy in reversing endothelial dysfunction.

Main Methods:

  • Studied basal and muscarinic agonist-stimulated NO-mediated vascular tone.
  • Assessed endothelial function in coronary, forearm, and cutaneous resistance vessels.

Related Experiment Videos

  • Evaluated endothelial function in conduit vessels (coronary and forearm).

    • Main Results:

    • Impaired NO-mediated vascular tone components were observed in hypertensive patients.
    • Endothelial dysfunction was not universal among all patients studied.
    • Antihypertensive therapies showed limited success in reversing observed endothelial dysfunction.

    Conclusions:

    • Endothelial dysfunction is a significant consequence of hypertension, potentially driving atherosclerosis.
    • The precise mechanisms underlying this dysfunction and its relationship to blood pressure require further elucidation.
    • Current therapeutic strategies are insufficient to fully restore endothelial function in hypertensive individuals.